Coxiella burnetii infection Q-fever
Conditions
Interventions
None listed
Sponsors
RIVM
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - Signed Informed Consent - willing to adhere to blood draw schedule - has taken part in the national Q-fever vaccination campaign
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Humoral immune response: IgG and IgM antibodies against fase 1 and 2 antigens of C. burnetii are measured by means of several serological tests:: immune fluorescence assay (IFA), enzyme-linked immuno sorbent assay (ELISA), complement binding reaction (CBR), polymerase chain reaction (PCR) and micro-array. Cellular immune response: After stimulation of whole blood, the levels of interferon-gamma (IFN-gamma), interleukine (IL)-10 and possibly IL-12 production are measured. Also a T-helper 1 and T-helper 2 cytokine profile are measured in isolated mononuclear cells, isolated CD14+ monocytes and isolated T-cells after stimulation, and differentiation of the cells is studied. | — |
Countries
Netherlands
Outcome results
None listed